meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Hepatic disease / Liver disease
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Efficacy parameters relevant to liver diseases: BMI, ALT, AST, gamma-GT, CHOL, HDL-c, LDL-c, TAG, CRP, TNF-alfa
Liver diseases pose a significant global health challenge, leading to approximately 2 million deaths annually. The primary drivers of these fatalities are cirrhosis, viral hepatitis, and hepatocellular carcinoma (HCC) (). These conditions are intricately linked to both innate and adaptive immunity, with elevated systemic inflammation and immune dysfu…
References (Sources)
- Altered profile of human gut microbiome is associated with cirrhosis and its complications
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
- Global burden of liver disease: 2023 update
- Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality
- Pathogenesis of autoimmune hepatitis
- The Gut Barrier, Gut Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to ManageReview
- X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis